Slate Path Capital LP
Q1 2014 13F-HR Holdings
Net value change ($000)
-1,576,628
(-54.4%)
New positions
3
Sold out positions
7
Turnover %
91.4%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2013
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| Endo International plc | 152,060 | NEW |
| B | 142,640 | NEW |
| ARIAD PHARMACEUTICALS INC | 53,357 | NEW |
| TCOM | 35,277 | 28.4% |
| PANDORA MEDIA INC | 33,111 | 29.3% |
| ZYNGA INC | 8,446 | 17.6% |
Top Reduces (Value $000, Stocks/ETFs)
| ENDO PHARMACEUTICALS HLDGS | -254,662 | -100.0% |
| MPC | -160,969 | -61.3% |
| Alphabet Inc. Class C | -145,692 | -100.0% |
| YOUKU.COM INC | -134,987 | -100.0% |
| LEVEL 3 COMM | -99,676 | -100.0% |
| ENOV | -94,898 | -100.0% |
| PSX | -79,058 | -100.0% |
| AIG | -66,876 | -33.1% |
| ISRG | -51,083 | -100.0% |
| LNG | -47,854 | -40.5% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|